Chen Chia-Yen, Liao Yung-Ming, Tsai Wei-Ming, Kuo Hann-Chorng
Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
J Formos Med Assoc. 2007 Dec;106(12):992-8. doi: 10.1016/S0929-6646(08)60074-1.
BACKGROUND/PURPOSE: This study investigated the incidence of upper urinary tract urothelial carcinoma (UUT-UC) in eastern Taiwan and its association with chronic kidney disease (CKD).
A total of 110 patients with histologically proven UUT-UC over a recent 20-year period were retrospectively analyzed to determine the clinical profile, overall survival and correlation with CKD.
The mean age at diagnosis was 68.7 +/- 9.8 years (range, 43-93 years), and the male to female ratio was 1 to 1.16 (51:59). The ratio of urothelial carcinoma (UC) of the renal pelvis to UC of the ureter to UC of the bladder was 1.2:1:6.7. UC of the renal pelvis accounted for 10.8% of all urinary tract UC, and for 41% of all renal cancer detected during the study period. The 2-, 5- and 10-year cancer-specific survival rates of patients with UUT-UC were 75%, 53.0% and 29%, respectively. Patients with high grade and high stage UUT-UC had significantly worse prognosis than those with low grade (p = 0.0047) and low stage (p = 0.0021). Of the 110 patients, 64 (58%) had impaired renal function (glomerular filtration rate < 60 mL/min/1.73 m2; defined as CKD), including 14 (13%) with end-stage renal disease (ESRD) before diagnosis. Patients with CKD or ESRD had significantly worse prognosis than those with normal renal function (p = 0.0399). High grade UC was found in 35 of 58 patients with CKD or ESRD (60%), which was significantly higher than in patients with normal renal function (12/26, 26%; p = 0.019).
A high proportion of UUT-UC was observed among all UCs and a significantly higher percentage of high grade UUT-UC (60%) were found in patients with CKD or ESRD in eastern Taiwan. These findings suggest that CKD and ESRD might play a role in the development of UC especially in the upper urinary tract.
背景/目的:本研究调查了台湾东部上尿路尿路上皮癌(UUT-UC)的发病率及其与慢性肾脏病(CKD)的关联。
回顾性分析了近20年间110例经组织学证实的UUT-UC患者,以确定其临床特征、总生存率以及与CKD的相关性。
诊断时的平均年龄为68.7±9.8岁(范围43-93岁),男女比例为1:1.16(51:59)。肾盂尿路上皮癌(UC)、输尿管UC和膀胱UC的比例为1.2:1:6.7。肾盂UC占所有尿路UC的10.8%,占研究期间所有肾癌的41%。UUT-UC患者的2年、5年和10年癌症特异性生存率分别为75%、53.0%和29%。高分级和高分期UUT-UC患者的预后明显差于低分级(p = 0.0047)和低分期(p = 0.0021)患者。110例患者中,64例(58%)肾功能受损(肾小球滤过率<60 mL/min/1.73 m2;定义为CKD),其中14例(13%)在诊断前患有终末期肾病(ESRD)。CKD或ESRD患者的预后明显差于肾功能正常的患者(p = 0.0399)。58例CKD或ESRD患者中有35例(60%)发现高分级UC,显著高于肾功能正常的患者(12/26,26%;p = 0.019)。
在所有UC中观察到高比例的UUT-UC,在台湾东部,CKD或ESRD患者中发现高分级UUT-UC的比例显著更高(60%)。这些发现表明,CKD和ESRD可能在UC尤其是上尿路UC的发生发展中起作用。